alprazolam and gsk 561679

alprazolam has been researched along with gsk 561679 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, A; Ernst, M; Grillon, C; Hale, E; Lieberman, L; Pine, DS	1

Trials

1 trial(s) available for alprazolam and gsk 561679

Article	Year
The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Mar-13, Volume: 40, Issue:5 Topics: Acoustic Stimulation; Adult; Alprazolam; Anti-Anxiety Agents; Anticipation, Psychological; Anxiety; Azabicyclo Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroshock; Fear; Female; Humans; Neuropsychological Tests; Oxadiazoles; Psychotropic Drugs; Receptors, Corticotropin-Releasing Hormone; Reflex, Startle; Surveys and Questionnaires; Uncertainty	2015

Article

Year

The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Mar-13, Volume: 40, Issue:5

Topics: Acoustic Stimulation; Adult; Alprazolam; Anti-Anxiety Agents; Anticipation, Psychological; Anxiety; Azabicyclo Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroshock; Fear; Female; Humans; Neuropsychological Tests; Oxadiazoles; Psychotropic Drugs; Receptors, Corticotropin-Releasing Hormone; Reflex, Startle; Surveys and Questionnaires; Uncertainty

2015